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Abstract
Background: HLA-DM (DM) mediates exchange of peptides bound to MHC class II (MHCII) during the epitope selection
process. Although DM has been shown to have two activities, peptide release and MHC class II refolding, a clear
characterization of the mechanism by which DM facilitates peptide exchange has remained elusive.
Methodology/Principal Findings: We have previously demonstrated that peptide binding to and dissociation from MHCII in
the absence of DM are cooperative processes, likely related to conformational changes in the peptide-MHCII complex. Here
we show that DM promotes peptide release by a non-cooperative process, whereas it enhances cooperative folding of the
exchange peptide. Through electron paramagnetic resonance (EPR) and fluorescence polarization (FP) we show that DM
releases prebound peptide very poorly in the absence of a candidate peptide for the exchange process. The affinity and
concentration of the candidate peptide are also important for the release of the prebound peptide. Increased fluorescence
energy transfer between the prebound and exchange peptides in the presence of DM is evidence for a tetramolecular
complex which resolves in favor of the peptide that has superior folding properties.
Conclusion/Significance: This study shows that both the peptide releasing activity on loaded MHCII and the facilitating of
MHCII binding by a candidate exchange peptide are integral to DM mediated epitope selection. The exchange process is
initiated only in the presence of candidate peptides, avoiding possible release of a prebound peptide and loss of a potential
epitope. In a tetramolecular transitional complex, the candidate peptides are checked for their ability to replace the pre-
bound peptide with a geometry that allows the rebinding of the original peptide. Thus, DM promotes a ‘‘compare-
exchange’’ sorting algorithm on an available peptide pool. Such a ‘‘third party’’-mediated mechanism may be generally
applicable for diverse ligand recognition in other biological systems.
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Introduction
Antigen presentation to CD4+ T lymphocytes by major
histocompatibility complex class II (MHCII) molecules is deter-
mined by a series of complex cellular and molecular events
occurring within antigen presenting cells. Proteins derived from the
secretory or endocytic pathway are proteolytically cleaved into
peptide fragments and loaded into MHCII within specialized
endosomal vesicles termed MHC class II compartments (MIIC).
The binding of a peptide to the MHCII involves interactions
between peptide side chains and pockets lining the MHCII peptide
binding groove as well as a conserved, extensive hydrogen bond (H-
bond) network between the peptide backbone and the MHCII [1].
MHCII molecules are transported from the endoplasmic
reticulum to the MIIC as nonameric complexes with the
chaperone protein invariant chain (Ii). Ii stabilizes the nascent
MHCII and prevents the binding of other endoplasmic reticulum-
resident peptides. Upon arrival in the MIIC, the Ii molecule is
cleaved through the action of proteases leaving a peptide fragment
termed CLIP in the MHCII peptide-binding groove [2]. CLIP is
then released by the action of a class-II like molecule called HLA-
DM (DM) to allow antigenic peptide to bind MHCII [3–6]. DM’s
exchange role is not limited to CLIP as it can catalyze the
exchange of antigenic peptide to select for a kinetically stable
peptide/MHCII repertoire [7–10]. DM has also been shown to
stabilize unbound MHCII from the irreversible loss of the peptide
binding site or rescue misfolded MHCII from denaturation and
aggregation [11,12].
DM mediated peptide exchange is usually examined in terms of
one of its functions, enhancing the release of the prebound
peptide. In this regard, several studies have identified possible
interaction sites between MHCII and DM during peptide release
PLoS ONE | www.plosone.org 1 November 2008 | Volume 3 | Issue 11 | e3722[13,14]. Other data has shown the importance of H-bonds in the
N-terminal region of the peptide binding groove for peptide/
MHCII stability [15] and the possible role of DM in the
destabilization of this region [16]. The importance of a conserved
H-bond at residue 81 in the MHCII b chain in peptide/MHCII
complex stability has also been shown in the absence [17] and
presence of DM [18].
Studies of peptide exchange in the absence of DM have proven to
be surprisingly complex for a non-covalent ligand/receptor interac-
tion. One complicating factor is the important observation that the
relatively slow level of spontaneous peptide release can be enhanced
by the presence of a second peptide, a phenomenon referred to as
‘‘pushing off’’ [19]. Indeed, the existence of a two peptide–MHCII
intermediate in this process was suggested by fluorescence energy
transfer (FRET). However, the effect of a second peptide on DM-
mediated peptide exchange reaction has not been investigated. The
ability of DM to stabilize an open conformation of MHCII or recover
partially denatured or aggregated MHCII may also play a role in the
mechanism of peptide exchange. Models invoking this function
propose that DM preferentially interacts with empty MHCII and
catalyzes a conformational change which facilitates the binding of
available peptides [11,12,20].
One way to approach the problem of complexity in peptide/
protein interactions is through the analysis of cooperative effects
during binding and dissociation. We have previously shown that in
the absence of DM, the binding of peptide to HLA-DR1 can be
described using a cooperative model in which the contribution of a
specific residue to peptide/MHCII affinity is dependent upon
peptide/MHCII interactions throughout the binding site [21,22].
We consider cooperativity as reflecting the folding process through
which the peptide and the binding groove may achieve a stable
conformation, consistently with the interpretation given in other
systems [23]. Cooperative effects throughout the peptide binding site
would also provide an explanation for the fact that both types of
binding energy available to the peptide/MHCII complex (hydro-
phobic interactions and hydrogen bonding) can influence DM
stability [16,24]. Under a cooperative model of peptide/MHCII
interactions, DM would discriminate among peptide sequences based
on the total binding energy resulting from distributed interactions
across the peptide-binding groove. Indeed, peptide substitution of
solvent-exposed side chains, as well as modification of the P1 pocket
interaction affect complex stability in the presence of DM [25].
Here we investigate whether DM action on the complex affects
cooperativity and how this may be related to the mechanism
underlying the peptide exchange reaction. First we show that
cooperative effects are only measured at the level of the exchange
peptide. An important role for the exchange peptide is further
supported by the lack of efficient peptide exchange in the absence of a
high affinity exchange peptide at sufficient concentration. Increased
FRET signal between the bound and exchanging peptide in the
presence of DM provides support for the requirement of a
tetramolecular intermediate in the mechanism of DM-mediated
exchange. Our results suggest that DM mediates epitope selection by
a ‘‘compare-exchange’’ sorting process in which bound peptide
release occurs only in the presence of exchange peptides, and these
are tested by MHCII on the basis of their folding properties in the
contextof ageometry that allows for rebindingof the original peptide.
Results
Absence of cooperativity in DM-mediated peptide
release of the prebound peptide
In our previous work, we have shown that the transition
between the empty and bound conformer of peptide/MHCII
complexes in the absence of DM is cooperative; in that the total
binding energy of the complex is dependent on distributed
interactions across the peptide-binding groove [21,22]. Moreover,
previous kinetic analyses of DM function have suggested that DM
acts as a conformational catalyst to promote the conversion
between the empty and bound conformation of the peptide/
MHCII complex [16]. Therefore we investigated how the
presence of DM may impact cooperativity, i.e. the folding/
unfolding of the complex.
A general strategy for the direct analysis of cooperativity is the
mutant cycle approach devised by Fersht and colleagues [23,26].
The experimental approach involves introducing a defined
number of substitutions into the amino acid sequence of a protein.
Next, the individual contribution of each substitution to the
energetics of protein folding or catalytic activity is measured.
Cooperativity between protein subunits is evidenced by a
disproportionate effect in the presence of multiple substitutions
than predicted by an analysis of each individual mutation.
To measure cooperative effects in DM-mediated peptide
exchange, we utilized a series of hemagglutinin (HA) peptides
substituted at the P2, 3, 7, and 10 positions, which are postulated
to mediate their negative effects on affinity by interfering with the
hydrogen bonding network [25]. In brief, molecular modeling
studies suggest that the P2 Val to Ser substitution would affect H-
bonds between b-82 Asn and the P2 amide and carbonyl groups.
The P3 mutation, Lys to Asp, is postulated to destabilize the H-
bonds between a9 Gln and a62 Asn with the carbonyl of P4. The
substitution at P10, Val to Gly, is postulated to disrupt the H-bond
between a76 and the P10 carbonyl. In addition to direct
interference of hydrogen bonding, these substitutions may act
indirectly to destabilize hydrogen bond interactions by increasing
solvent accessibility. The P7 Leu to Pro substitution likely mediates
its affect on affinity through steric interactions at the shallow
hydrophobic pocket at the P7 position [27].
We first asked whether cooperative effects in the presence of
DM would be measurable at the level of the peptide prebound in
the HLA-DR1 (DR1) groove. Dissociation rate data for these
peptides in the presence of DM are shown in Figure 1a and the
t1/2 values are reported in Table 1A. Cooperative effects were
calculated by determining the ratio of expected t1/2 to observed t1/
2 for each substituted peptide relative to the off-rate of the DR1/
HA complex in the presence of DM. When cooperativity was
plotted against the observed t1/2 of the various DR1/peptide
complexes (Figure 1b, solid line), we found a very poor
correlation (r
2=0.37), with a slightly positive slope. Interestingly,
this was in contrast to the negative slope of cooperativity vs. off-
rate in the absence of DM (Figure 1b, dashed line from ref. 21).
Therefore, peptide release in the presence of DM is different from
the typical unfolding process observed in the absence of DM.
Cooperativity is observed in the exchange peptide
during DM-mediated exchange
An integral aspect of measuring KD, intrinsic off rates and DM-
mediated release is the presence of an exchange peptide, also
called ‘‘competitor’’. This is usually an unlabeled peptide
nominally added in excess to the reaction to prevent the rebinding
of freshly dissociated labeled peptide. However, the presence of the
exchange peptide is a parameter whose effect is incompletely
understood. To address the role of the exchange peptide in DM
activity, we selected a peptide which had an appreciable off-rate in
the presence of DM. In our previous experiments, a HA peptide
containing a Ser for Val mutation at P2 (P2 VRS) (HAS) was
found to have a small effect on affinity as compared to wild-type
HA, but significantly increased dissociation rate in the presence of
Compare-Exchange Action for DM
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were measured in presence of DM and in the presence of 100-fold
excess of different exchange peptides (Figure 1c and Table 1B).
To control for the effect of the P2 (VRS) mutation, each exchange
peptide tested also contained the P2 mutation.
The half-life values were used to calculate cooperativity relative
to the exchange peptide. We found cooperativity with a high
correlation (r
2=0.99) and with a slope of 20.99 (Figure 1d). In
addition, the relationship between cooperativity and t1/2 was
similar to that obtained in the absence of DM when cooperativity
was defined relative to the bound peptide (Figure 1b, open
circles). Since all the substitutions introduced in the HA sequence
are postulated to destabilize binding, our assays measure a
negative cooperative effect on complex stability. These results
suggested that during peptide exchange in presence of DM, the
exchange peptide may replace the prebound peptide based on its
ability to form a stable conformer of the peptide/MHCII complex.
The observation that cooperativity was detected in the exchange
peptide during DM-mediated exchange raised the question
whether cooperativity could be observed in the absence of DM.
To address this issue we measured DR1/HAS complex stability in
the same conditions but without DM. Dissociation rate data are
shown in Figure 1e and the t1/2 values are reported in Table 1C.
Interestingly, when we calculated the values of cooperativity for
the exchange peptide in the absence of DM, we found a similar
negative slope as measured in the presence of DM (Figure 1f) but
to a lesser extent (slope of 20.68 vs. 20.99).
The affinity of the exchange peptide for the DR1 binding
groove affects DM mediated peptide release
The cooperativity data indicated a mechanistic relationship
between the non-cooperative release of the prebound peptide and
the cooperative binding of the exchange peptide. Interestingly, the
off-rate experiments in Figure 1c and 1e also show that the t1/2
of the DR1/HAS complex varied considerably based on the
affinity of the exchange peptide for DR1. When a HA-derived
peptide with a single or a double substitution was present in excess,
the dissociation rates of the prebound peptide were similar, with a
t1/2 of approximately 85–90 min (table 1B). However when the
affinity of the exchange peptide was decreased through multiple
substitutions, we found that the stability of the DR1/HAS
complex was significantly increased (309 min for HASDPG,
table 1B). A similar trend could be observed when complex
stability was measured in absence of DM. When the normalized
t1/2 values of DR1/HAS complex were plotted against the
normalized KD of the various exchange peptides [21], we found a
positive exponential correlation either in the presence (Figure 1g)
or in the absence of DM (Figure 1h). These data indicate that the
exchange peptide promotes prebound peptide release at a rate
which is a function of its affinity for DR, and DM affects the
exchange reaction through enhancement of this effect.
DM mediated peptide exchange is dependent on an
exchanging peptide
In our previous experiments, the effect of the exchange peptide
was measured indirectly, by monitoring the release of labeled
prebound peptide. To more directly study the relationship
between the exchange peptide and release of prebound peptide,
we next asked whether DM would release prebound peptide in the
absence of an exchange peptide. This required an experimental
approach wherein the amount of free peptide would be directly
measured over longer time scales.
To this end, we utilized two different approaches to examine the
dependence of peptide release on the presence of exchange
peptide; electron paramagnetic resonance (EPR) and fluorescence
polarization (FP). The rationale for both methodologies was to
start with a prebound peptide/MHCII complex and observe the
accumulation of free peptide over time in the absence of an
exchange peptide, DM, or both. The missing component(s) was
then added to the reaction, and the exchange rate was monitored.
For the EPR studies we utilized a site directed spin labeling
(SDSL) approach coupled with EPR spectroscopy [28], to measure
the dissociation from HLA-DR1 of a peptide derived from the HA
peptide. The HA peptide was substituted with cysteine at P1, P3 or
P7 and labeled with MTSL, which introduces a stable free
electron-containing nitroxide moiety at the cysteine residue (see
methods). The modification at P3 and P7 resulted in a 3- and 5-
fold decrease in peptide binding to DR1 respectively, as measured
through a competition binding assay (Figure 2a), but still allowed
for stable complex formation. We selected the P7 substituted
peptide for further experiments, as the P7 LRC substitution
resides in a shallow hydrophobic pocket [27] which might be
expected to restrict rotation of the spin-label probe (HAsp7)
(Figure 2b). In EPR analysis, the labeled substrate undergoes a
Figure 1. Cooperative effect on peptide dissociation from HLA-DR1 in presence of DM is evidenced at the level of the exchange
peptide. (a) Dissociation rate of peptides from HLA-DR1 in the presence of DM was measured as described in Results. Data is plotted as the fraction
of DR1/labeled peptide complex remaining relative to t=0. Reactions were performed in triplicate, and data points represent one of two
independent experiments. Lines fit the data to a single exponential decay function. (b) Natural log (ln) plot of cooperativity (expected/observed t1/2)
vs. DM-mediated (solid line) and intrinsic (dashed line) dissociation rate for each DR1/peptide complex tested. To facilitate the comparison, data
points were plotted on different scales for t1/2 values. Top x-axis scale refers to intrinsic dissociation rate. Bottom x-axis scale refers to DM-mediated
off rate. Since we defined cooperativity C as the ratio of the expected to observed values for Dt1/2, and t1/2 is directly proportional to stability, the
cooperative effect is positive if 0#C,1, while if C.1 the cooperative effect is negative. In the ln plot, positive cooperativity in stability is indicated on
the y-axis by values ,0 and negative cooperativity by values .0. Horizontal error bars represent the SD of the t1/2 measurement. Vertical error bars
represent the error of cooperativity as calculated through SE propagation. Lines indicate the fit of the data to a linear regression. (c) DM-mediated
dissociation of the HAS peptide from DR1. The nature of the competing peptide present in excess during the reaction is identified in the legend. Data
points represent the mean of two independent experiments, and lines represent the fit of the data to a two or three parameter single exponential
decay function. (d) Natural log (ln) plot of cooperativity (expected/observed t1/2) vs. dissociation rate of DR1/HAS complex for each multiple
substituted exchange peptide tested. Error bars are as in panel B. The line indicates the fit of the data to a linear regression. (e) Intrinsic dissociation of
the HAS peptide from DR1. The nature of the competing peptide present in excess during the reaction is identified in the legend. Data points
represent the mean of two independent experiments, and lines represent the fit of the data to a two or three parameter single exponential decay
function. (f) Natural log (ln) plot of cooperativity (expected/observed t1/2) vs. dissociation rate of DR1/HAS complex for each multiple substituted
exchange peptide tested. Error bars are as above. The line indicates the fit of the data to a linear regression. (g) The ratio of t1/2 for the DR1/HAS
complex measured in the presence of different exchange peptides and DM as compared to the t1/2 measured in the presence of HAS is plotted as
function of the natural log of exchange peptide KD. The line indicate the fit of the data to an exponential function (r
2=0.98). (h) The ratio of t1/2 for
the DR1/HAS complex measured in the presence of different exchange peptides and in absence of DM as compared to the t1/2 measured in the
presence of HAS is plotted as function of the natural log of exchange peptide KD. The line indicate the fit of the data to an exponential function
(r
2=0.97).
doi:10.1371/journal.pone.0003722.g001
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static magnetic field. The resultant spectra are dependent on the
motion of the spin-label side-chain. Rapid tumbling of the spin
label in solution gives rise to three narrow lines (Figure 2c top).
As the rotational freedom of the probe becomes restricted (i.e.
upon MHCII binding), the EPR spectrum shows broadening of
the spectral lines and a shift in their relative positions within the
spectrum (Figure 2c center). EPR spectra are composites of all
motions present within a sample (e.g. Figure 2c bottom), and not
an average, thus peptide dissociation can be monitored and
quantified in real time without a separation step.
Spectra were acquired in the following reactions: DR1/HAsp7
in the presence of 3-fold molar excess DM; DR1/HAsp7
complexes in the presence of 100-fold excess unlabeled HA; and
DR1/HAsp7 complexes alone. As shown in Figure 2d, the
amount of free peptide present at t=0 hr averages 3% for all
reactions tested, confirming that nearly all of the HAsp7 peptide is
bound to DR1. After 24 hr, there was negligible release in the
presence of excess HA. Approximately 20% free peptide was
observed in the presence of DM. At this point, soluble DM was
added to the reaction with excess HA, and 100-fold excess
unlabeled HA peptide was added to the reaction with DM, and
incubation continued. Four hours after the addition of either DM
or peptide to the respective reactions, we observed an equivalent
increase in free HAsp7 peptide (60% over the 24 hr timepoint).
Furthermore, at 48 hr, when both an exchange peptide and DM
were added simultaneously to the incubation with DR1/HAsp7
complex alone (Figure 2d, closed circles), we observed a similar
Table 1. Dissociation rate of substituted peptide/DR1 complexes.
Complex Exchange Peptide Abbreviation (text and figures) t1/2 (min)
A
DR1/HA 306-319 HA (306-319) HA 447.74675.4
DR1/P2 VRS HAS 60.32611.18
DR1/P7 LRP HAP 267.8646.2
DR1/P2,7 VLRSP HASP 40.3662.84
DR1/P10 ARG HAG 69614.4
DR1/P7,10 LARPG HAPG 92.9613.1
DR1/P3 KRD HAD 43.7866.12
DR1/P2,10 VARSG HASG 11.7262.18
DR1/P2,7,10 VLARSPG HASPG 9.960.7
DR1/P3,7 KLRDP HADP 15.8763.63
DR1/P2,3 VKRSD HASD 4.660.4
DR1/P3,10 KARDG HADG 7.9261.64
DR1/P3,7,10 KLARDPG HADPG *
DR1/P2,3,7 VKLRSDP HASDP *
DR1/P2,3,10 VKARSDG HASDG *
DR1/P2,3,7,10 VKLARSDPG HASDPG *
B
DR1/P2 VRS DR1/P2 VRS HAS 85.8610.1
DR1/P2,7 VLRSP HASP 90.6612.4
DR1/P2,10 VARSG HASG 85.169.1
DR1/P2,7,10 VLARSPG HASPG 102.462.5
DR1/P2,3 VKRSD HASD 89.665.2
DR1/P2,3,7 VKLRSDP HASDP 123.161
DR1/P2,3,10 VKARSDG HASDG 260.7626.3
DR1/P2,3,7,10 VKLARSDPG HASDPG 309.0649
C
DR1/P2 VRS DR1/P2 VRS HAS 19506183
DR1/P2,7 VLRSP HASP 19306164
DR1/P2,10 VARSG HASG 20806233
DR1/P2,7,10 VLARSPG HASPG 28106216
DR1/P2,3 VKRSD HASD 37206279
DR1/P2,3,7 VKLRSDP HASDP 38106453
DR1/P2,3,10 VKARSDG HASDG 84706700
DR1/P2,3,7,10 VKLARSDPG HASDPG 1310061684
*Not measured.
doi:10.1371/journal.pone.0003722.t001
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DR1/HAsp7 complex was stable and maintained the ability to
undergo peptide exchange after long incubation periods. The rate
of DM-mediated spin-labeled peptide release during the 4 hour
incubation in presence of excess unlabeled exchange peptide
shows a three-fold increase over the 24 hr incubation without
exchange peptide (60% vs. 20%) loss, suggesting that, under the
conditions tested, the exchange peptide plays a role as a co-factor
in the DM-catalyzed off rate.
FP analysis of the role of free peptide in DM-mediated
peptide dissociation
The acquisition of an EPR spectrum requires multiple scans (up
to 25). As such, each time point for a particular reaction represents
the average of several measurements. To more precisely measure
peptide exchange, we performed a similar experiment using
fluorescence polarization (FP). FP methodology takes advantage of
the fact that the light emitted by a fluorophore upon excitation
with plane polarized light is polarized as well. The angle between
the planes of exciting and emitted light is dependent on the
tumbling of the fluorophore. Therefore, if viscosity and temper-
ature are held constant, polarization is directly related to the
molecular volume. If a fluorescent probe binds to a molecule with
a higher molecular weight, this average angle will decrease due to
the slower molecular rotation of the bound probe. Thus, the ratio
between bound and free peptide can be measured directly in
solution without a separation step [29].
As shown in Figure 3a, we measured DR1/FAM labeled P7
LRC (HAC) complex stability under similar conditions as in the
previous EPR assay. Again we observed a slow peptide off rate
during the first 24 hours, which was greatly accelerated when
exchange peptide, DM, or both were added to the respective
reactions. Again, we observed a slight increase in off-rate during
the first 24 hr in the presence of DM (18% loss) as compared to
incubation in the presence of excess exchange peptide (3% loss),
suggesting that the effect of DM incubation observed in the SDSL
experiments was not an artifact of the experimental system used.
Figure 2. Free peptide is a co-factor in DM-mediated peptide release. (a) Competitive binding analysis of P1, P3 and P7 MTSL-Cys
substituted HA peptide variants to DR1. Data represent the mean and SD of three independent experiments. Lines indicate the fit of the data to a
logistic equation. KD values for the peptides as listed in the legend are respectively 83.3 nM, 28.8 mM, 237.9 nM and 404.7 nM. (b) Top view of the HA
peptide P7 LeuRCys substituted, labeled at this position with MTSL (HAsp7) and complexed with HLA-DR. The peptide is in orange, the a-chain is in
green and the b-chain in yellow. The most energetically favored orientation of the probe (white) is shown. The model was generated using PyMol
[45]. Coordinates taken from ref. 41. (c) Spectra of HAsp7 peptide as recorded when free in solution (top), completely bound to HLA-DR (center) or as
a composite of the two states (bottom). The broadening of the spectral lines and a slight shift in their positions in the spectrum appear evident. (d)
Dissociation of HAsp7 peptide from DR1 was measured as described in Results. Data is plotted as the % of free (unbound) peptide detected at each
time point as quantitated by spectral subtraction methods. Data points represent one of three independent experiments. Data points referring to the
C sample at t=0 and t=24 are hidden below other data points.
doi:10.1371/journal.pone.0003722.g002
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process, we next asked whether the dependence of DM catalysis on
the nature of the exchange peptide would be observed with CLIP
prebound in the peptide binding groove. As shown in Figure 3b,
we found similar results with DR1/CLIP complex stability in
presence of DM.
We also investigated the relationship between exchange peptide
affinity and release of prebound CLIP. For these experiments,
DR1/CLIP complexes were used to test the effect of higher and
lower affinity exchange peptides with respect to the peptide bound
in the DR1 groove. As shown in Figure 3c, and consistent with
the results presented in Figure 1, the rate of dissociation of the
CLIP from DR1 varied considerably based on the affinity of the
excess competitor peptide for DR1. When a high affinity exchange
peptide such as wild type (wt) HA peptide was present in excess,
the dissociation rate of the CLIP fitted to a double exponential
decay, with a t1/2 of approximately 80 min. However, when the
affinity of the exchange peptide was decreased either through P9
substitution (P9 LRP), P1 substitution (P1YRA) or through
multiple substitutions at positions with intermediate solvent
accessibility (HASDPG), we found that the dissociation of the
CLIP in the presence of DM was significantly reduced. None of
the exchange peptides could promote a complete release of CLIP,
since the largest CLIP/DR1 complex dissociation measured was
on the order of 55% in the presence of excess HA. This
observation may be related to the presence of a consistent fraction
of complex unable to undergo the conformational changes needed
for DM-mediated exchange. Interestingly, we found that as the
affinity of the exchange peptide for DR1 decreased the relative
contribution of the slow phase to the dissociation increases. During
the slow phase, an equilibrium was established that appeared to be
dependent on the affinity of the exchange peptide for DR1. For
example, in the presence of an extremely low affinity exchange
peptide such as HASDPG, the equilibrium is established at similar
levels (<90%) to that observed in the absence of exchange peptide.
DM-mediated exchange is dependent on the
concentration of the exchange peptide
We observed that DM efficiently mediates the release of the
prebound peptide during the exchange reaction only in the
presence of an exchange peptide. Furthermore, the prebound
peptide off-rate depends on the nature of the exchange peptide. By
logical extension, if exchange requires a peptide of a certain
affinity, then concentration of the reactants could be important.
To address this question, we measured DM-catalyzed release of
HAS from DR1 in the presence of different concentrations of
unlabeled HA. As shown in Figure 4a, HAS dissociation varied
considerably based on the concentration of the exchange peptide.
While no significant release was measured for lower concentra-
tions (0.1 and 0.5 fold relative to the peptide/MHCII complex),
peptide exchange was observed at a 1:1 ratio and higher.
An alternative explanation for the apparent stability of the
peptide/MHCII complex in the absence of competitor peptide
might be that the unlabeled peptide serves to prevent rebinding of
the freshly dissociated pre-bound peptide. Under this model, the
slower off rate could be due to formation of an equilibrium
between dissociation and re-association. In our experiments, the
initial complex concentration is very low, reducing the probability
of re-assocation by simple Brownian motion in solution. However,
we directly tested this possibility by measuring the stability of the
CLIP/DR complex at three initial concentrations spanning one
logarithm (100, 300, 900 nM), in the presence of DM without
exchange peptide. Simultaneously, we measured the DM-mediat-
ed on rate of FAM-CLIP to an equimolar amount of DR at the
Figure 3. FP analysis of the role of free peptide in DM-
mediated peptide dissociation. (a) Real-time analysis of DR1/HAC
stability as described in Results. (b) Real-time FP analysis of DR1/CLIP
stability as described in Results. For (a) and (b) initial reaction conditions
are identified in the legend. Data is plotted as the % of bound peptide
detected at a certain time point. Reactions were performed in triplicate,
and data points represent one of two independent experiments. (c)
DM-mediated dissociation of the CLIP peptide from DR1. The nature of
the exchange peptide present in excess during the reaction is identified
in the legend. Data points represent the mean of three independent
experiments, and lines represent the fit of the data to a five parameter
double exponential decay function. Due to the small SD, error bars are
hidden below data points.
doi:10.1371/journal.pone.0003722.g003
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both DR and peptide increased, the probability of peptide binding
to DR should increase accordingly as measured by the plateau of
the peptide on-rate. A corollary is that for low concentration
samples, the on-rate steady state is a fraction of that detected in the
corresponding release assay.
As shown in Figure 4b, DM-mediated CLIP release in the
absence of any unlabeled peptide is essentially the same for all the
concentrations tested, reaching an equilibrium at 80% of bound
peptide. This indicates that the fraction of bound (and free)
peptide at any time-point is not a function of the initial complex
concentration. On the contrary, during a loading assay, the
fraction of bound peptide at the steady state depends on peptide
and DR concentration, as predicted. In particular, at 100 nM,
which corresponds to the concentration usually adopted in our
experiments, a significant difference between peptide release and
peptide binding at equilibrium is evident; thus, the plateau
established during a peptide off rate can not be explained simply as
a cycle of release and rebinding. Moreover, this provides further
support for the model that the unlabeled peptide is not only
replacing the pre-bound but actively participating in DM action.
Interestingly, DM contribution to peptide association appears
more significant than DM contribution to peptide release, as the
effect of DM on complex formation is greater than complex
dissociation for all the samples tested.
On the basis of this result and the finding that free peptide
concentration affects complex stability (Figure 4a), we speculated
that the kinetics during peptide release in the presence of DM is
determined by the rate at which DM promotes the loading of the
free peptide. To test this hypothesis we compared the DM
mediated release of the prebound peptide in the presence of a
specific concentration of exchange peptide with the DM mediated
association of the exchange peptide to empty DR at that same
concentration.
Figure 4. DM mediated peptide exchange as function of reactant concentration. (a) Requirement of equimolar exchange peptide for
initiating exchange. DM-mediated dissociation of the peptide HAS from DR1 measured in the presence of different concentration of unlabeled HA in
excess as described in Results. The exchange peptide to complex ratio for each reaction is identified in the legend. Data points represent the mean
and SD of three independent experiments, and lines represent the fit of the data to a five parameter double exponential decay function. (b) FP
analysis of DM-catalyzed peptide binding to and release from DR. CLIP/DR complex at different concentrations (100, 300, 900 nM) was incubated with
3 fold DM and allowed to dissociate in absence of any free peptide. Simultaneously, loading of FAM-CLIP to an equimolar amount of DR at the same
concentrations was measured. Reactions were set up in triplicates, and the average 6SDs are shown. Lines represent the fit of the data to either a five
parameter double exponential decay or four parameters double exponential raise function. (c) Peptide release in the absence of exchange peptide is
not a function of complex concentration. FP analysis of DM-catalyzed release of HAD from DR at four different concentrations in absence of any free
peptide. At t=1000 after steady state was reached, unlabeled peptide was added at an equimolar concentration to the complex at t=0. Reactions
were set up in triplicates, and the average values for each time point are shown. (d) DM-mediated binding is a function of reactant concentration. FP
analysis of DM-catalyzed association of HAD to equimolar empty DR at the same four different concentrations as in panel B. Lines represent the fit of
the data to a four parameter double exponential function. For (c) and (d), due to the small SD, error bars are hidden below data points.
doi:10.1371/journal.pone.0003722.g004
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HAD complex were allowed to reach equilibrium in the presence
of 3 fold excess DM and in the absence of exchange peptide.
Under these conditions, the small fraction of HAD released from
DR1 is essentially the same for all the concentrations of DR1/
HAD complex tested. As observed for CLIP, the percentage of
bound (and free) peptide at any particular time-point in the
absence of exchange peptide is not a function of the initial complex
concentration. Next, unlabeled HAD peptide was added in
equimolar amounts with respect to the initial complex concentra-
tion. For the results reported in Figure 4a, a 1:1 exchange
peptide as to complex ratio is sufficient to promote peptide
exchange. As shown in Figure 4c, the rate of peptide exchange
was dependent on the absolute concentration of exchange peptide,
despite being present at equimolar amounts. Interestingly, we
found that the extent of DR1/peptide complex depletion was
related to the maximal plateau of DR1/peptide complex
formation in the presence of DM (Figure 4d), indicating that
the ability of DM to mediate peptide exchange is dependent on the
ability of exchange peptide to bind DR1 in the presence of DM.
Direct analysis of cooperativity in DM-mediated peptide
association
One possible explanation for these data is a mechanism by
which DM is sensitive to the presence and nature of possible
epitopes, thereby actively facilitating of the binding of the
exchange peptide. Indeed, the cooperativity measured at the level
of the exchange peptide as shown in Figure 1(c–f) is indirect
evidence for DM mediated peptide/MCHII folding. To directly
measure cooperativity in DM-mediated binding of peptide to
DR1, we utilized FP to monitor the loading of different peptides to
an equimolar amount of empty MHCII (100 nM) in the presence
of a 3 fold excess of DM (Figure 5a). In these experiments,
cooperativity was calculated as expected to observed ratio of the
normalized Keq. As shown in Figure 5b, plotting cooperativity
against the observed Keq of each peptide, an exponential
relationship was revealed, with cooperativity increasing as peptide
association decreased (slope 20.65). Thus, the cooperativity we
observed in the release of prebound peptide as the affinity of the
exchange peptide was varied was replicated when we directly
measured the DM-mediated binding of the exchange peptide into
empty DR.
Co-localization of prebound and free peptide during DM-
mediated exchange
Given the dependence of DM-mediated peptide exchange on
the presence of an exchange peptide, the mechanism of DM-
mediated peptide exchange requires three molecular species; the
prebound peptide/MHCII complex, exchange peptide, and DM.
One possible mechanistic explanation for our findings would be
the formation of a transient two-peptide/MHCII intermediate
during the exchanging reaction. Indeed, evidence for formation of
a two-peptide/MHCII intermediate in the absence of DM has
previously been reported [19,30]. Measurement of fluorescence
resonance energy transfer (FRET) from aromatic residues in the
MHCII protein to labeled peptide side chains has been previously
utilized to monitor peptide binding, complex dissociation, and the
formation of a two-peptide/MHCII complex [19,30,31]. In
general, the intermolecular distance between fluorescent donor
and acceptor determines the strength of the FRET signal.
Therefore, we asked whether we would observe a measurable
FRET signal between the exchange and prebound peptide during
the DM-mediated exchange reaction.
To address this question, we formed DR1 complexes with N-
terminally FAM-labeled HA peptides containing the P3 (KRD)
mutation. Next, we constructed an exchange peptide consisting of the
wild type HA sequence labeled with a quencher probe (QSY-7-HA)
at the N-terminus. QSY-7 is a non-fluorescent diarylrhodamine
derivative that has strong absorption in the FAM emission spectrum
without direct acceptor excitation. The presence of the QSY-7 probe
had minimal (3-fold) effects of HA affinity for DR1 as shown by a
competitive binding assay (data not shown). We then measured the
off rate of HAD in the presence of QSY-7-HA and unlabeled wild-
typeHAinth eprese ncean dabsenceofDM.Assh owninFigure6a,
the presence of the QSY-7 moiety did not significantly affect the
ability of the wild-type HA peptide to compete for the DR1 binding
groove in the presence or absence of DM.
We next measured the ability of the QSY-7-HA to quench the
FAM fluorescence in the presence or absence of DM. As shown in
Figure 6b, we detected a 20% decrease in fluorescence signal
during the HAD off-rate performed in the presence of QSY-7-HA
and DM as compared to the control (p,0.0001), indicating that a
significant energy transfer was occurring during the exchanging
Figure 5. Direct measure of cooperativity in DM-mediated
peptide association. (a) Association rate of peptides to DR1 in the
presence of DM was measured as described in Results. Data is plotted
as the fraction of either peptide or DR1 forming complex. Reactions
were performed in triplicate, and data points represent one of three
independent experiments. Error bars are omitted for graphic clarity.
Lines fit the data to a four parameter double exponential function. (b)
Natural log (ln) plot of cooperativity (expected/observed Keq) vs.
association rate for each peptide tested. Error bars are as in figure 1b.
The line indicates the fit of the data to a linear regression.
doi:10.1371/journal.pone.0003722.g005
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compared to the control when performed in absence of DM,
indicating a less frequent co-localization during intrinsic peptide
release (p,0.0001). This difference was not due to either random
collisions between free peptides or a nonspecific action of DM on
the two peptides, as no significant loss of fluorescence was measured
in either of these cases. These data suggest that during peptide
release, there is a time when the two peptides are within 35–55 A ˚ of
each other, and suggest that transient formation of a two peptide/
MHC intermediate is enhanced in the presence of DM.
Discussion
Despite its importance in epitope selection, the mechanism of
DM-mediated peptide exchange remains unclear. In this work, we
show that the efficient release of the prebound peptide during a
DM-mediated exchange reaction requires the presence of an
exchange peptide. Furthermore, the ability of the exchange
peptide to act as a co-factor in the displacement is dependent on
its ability to bind MHCII, as judged by affinity. Moreover, the
exchange reaction requires a threshold concentration of the
exchange peptide. Enhanced cooperative effects measured during
peptide dissociation in the presence of DM are observed at the
level of the exchange peptide, not at the level of the prebound
peptide. Cooperativity is also observed at the level of DM-
mediated peptide binding in the absence of a prebound peptide.
Finally, in the presence of DM, there is an increased frequency of
co-localization of the exchange and prebound peptides interacting
with MHCII molecules.
Taken together, our data support a ‘‘compare-exchange’’ [39]
mechanism of DM action in which the presence of equimolar or
greater exchange peptide promotes a short lived tetramolecular
interaction involving DM, the MHCII-prebound peptide complex
and the exchange peptide. DM changes the structure of the
MHCII molecule, resulting in an extremely rapid release of the
prebound peptide. This release is not based on a gradual unfolding
process. It would include a large scale disruption of the hydrogen
bond network at the N-terminus of the peptide/MHCII binding
groove [16–18] and a weakening of the hydrophobic interaction at
P1, leading to wide-scale disruption of peptide/MHCII interac-
tions throughout the binding groove. Although destabilized, the
prebound peptide remains in the complex while DM maintains the
MHCII in an energetic state sensitive to the folding properties of
the exchange peptide. In the absence of productive folding of the
exchange peptide, the original prebound peptide can rebind to the
groove. The end result is that DM selects for exchange peptides
with the best chance of binding based on their affinity.
A key aspect of this mechanism is presence of a metastable
transition state in which two peptides may be accommodated in
close proximity to the binding groove. Some evidence in support
of a two-peptide/MHCII transition state is provided by FRET
experiments in which peptide to peptide energy transfer was
detected only in the samples containing a preformed complex and
an exchange peptide. Further support for this model is provided by
kinetic stability of peptide/MHCII complexes either in the
presence of DM or the absence of an exchange peptide. Previously
reported data in which a second peptide helps to release (or load)
another peptide based on its affinity [19,30,33] also support a
transient two peptide/MHCII state. Although estimates of the
relative proportion of the two-peptide/MHCII complex were low
in those studies, (1.0–0.1%), these complexes were preferentially
associated with the ‘‘open’’ conformer of the peptide/MHCII
complex during native PAGE analysis [30]. In keeping with the
reported correlation of two peptide intermediates and ‘‘open’’
conformers, we propose that the DM-associated two-fold increase
in interpeptide FRET indicates that DM senses the ‘‘open’’
MHCII resulting from the interaction with the two peptides.
If cooperative effects in the peptide association and dissociation
to MHCII in the absence of DM are directly related to coordinate
folding of the peptide and MHCII [21,22], then the lack of
cooperativity in DM-mediated peptide dissociation is striking, and
suggests that DM promotes a dramatic structural change in the
peptide/MHCII complex that does not follow the usual energetic
pathway of peptide/MHCII folding. One possibility is that DM
may promote a transient but catastrophic destabilization of the
pre-bound peptide/MHCII complex, possibly through alteration
of the three hydrogen bonds mediated by residues (51–53) of the
MHCII a chain [16] and 81 of the b chain [17,18]. This structural
change at the P1 region may then be transmitted rapidly
throughout the entire length of the peptide binding groove such
Figure 6. Co-localization of prebound and free peptide during
DM-mediated exchange. (a) DM-mediated and intrinsic dissociation
of HAD from DR1 was measured as described in Methods. The nature of
the exchange peptide present in excess during the reaction is identified
in the legend. Data points represent the mean of three independent
experiments, and lines represent the fit of the data to a five parameter
double exponential decay function. (b) Reduction of the overall
fluorescence due to FRET between FAM-labeled HAD and QSY7-HA
(shaded bars) either with (striped bars) or without (squared bars) DM as
compared with the fluorescence detected in presence of unlabeled free
HA peptide during the dissociation of HAD from DR1 (dark bars). Plain
bars represent the fluorescence detected in the following reactions:
HAD (dark bar), HAD+QSY7-HA (shaded bar) and HAD+QSY7-HA+DM.
doi:10.1371/journal.pone.0003722.g006
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by the lack of measurable cooperativity. Under these conditions of
widespread disruption of peptide/MHCII interactions, the
probability of close approximation of the prebound and exchange
peptides to a destabilized peptide binding groove is enhanced.
The subsequent peptide comparison and binding step of the
exchange reaction can be considered as either a stochastic
competition for the binding groove of the MHCII, or an ordered
process with the geometry of the retained pre-bound peptide and
the position of the exchange peptide favoring the latter’s access to
the groove. In either scenario, DM would promote the folding of
the peptide/MHCII complex to the final conformation. In a
stochastic competition, both peptides would simultaneously
attempt to fit into the groove, and half of these events would
result in rebinding of the original peptide when the two peptides
show the same affinity. In an ordered model, the exchange peptide
would be tested first and only if it was incapable of binding would
the prebound peptide return to the groove. Although we are
pursuing experiments to discriminate between these possibilities,
we do observe a difference in the cooperativity of binding in the
presence of the prebound peptide (Figure 1d, slope 20.99) vs.
that observed in the absence of the prebound peptide (Figure 5b,
slope 20.65) using largely empty soluble DR1 molecules. One
explanation for this difference would be that the by forming an
initial complex, the prebound peptide shifts the peptide/MHCII
complex into a conformer receptive to subsequent efficient
cooperative folding in the presence of a competitor peptide. In
vivo, the CLIP peptide may play a similar role.
We should point out that the selection of which peptide will fold
into the MHCII is restricted to the two peptides in the complex.
The MHCII is unavailable to third party peptides, as the
experiments shown in Figures 1a–b, as well as Figure 3c are
performed adding a large excess of exchange peptide and clearly
no mass action effect can be detected for peptides with intrinsic
low affinity for MHCII.
Mapping the location of the exchange peptide on the peptide/
MHCII complex in the presence or absence of DM will be an
important step in refining the mechanism. Due to the need for
diverse competitor peptide recognition, the most likely possibility is
that the incoming competitor peptide may associate with the
exchanging complex by forming partial hydrogen bond or
hydrophobic interactions with the destabilized peptide binding
groove. As the amino acid polymorphism in the peptide binding
groove across different MHCII alleles result in ‘‘anchor-pocket’’
interactions of varying strength, we expect that hydrogen bonding
may provide the majority of the binding energy for competitor
peptide recognition. However, we cannot entirely exclude the
possibility that the competitor peptide interacts with a distinct
(presumably less polymorphic) site present across MHCII alleles.
Experiments to chemically cross-link the competitor peptide
during the exchange reaction may provide some information
regarding the structure of the exchanging complex. An alternative
approach may be to examine mutagenized MHCII molecules for
their ability to undergo peptide exchangeability in the absence or
presence of DM [13].
Interestingly, we found that DM could promote a small, yet
measurable peptide release in absence of an exchange peptide.
Furthermore, this activity was independent of concentration
(Figure 4b). The phenomenon is likely related to the presence
of multiple conformers of the peptide/MHCII complex. At least
two isomers have been hypothesized, of which one would be
responsible for the slow phase and one for the fast phase of the
peptide release reaction [35–37]. Moreover, it has been proposed
that DM might distinguish between these isomers [32]. One
possibility is that in the presence of DM and absence of an
exchanging peptide we observe peptide dissociation from the ‘‘fast
release’’ conformers, on which the weak destabilizing action of
DM would be enough to promote peptide release. The ‘‘slow
release’’ isomers require an exchanging peptide for peptide
exchange. Experiments are currently underway to test this
hypothesis.
One limitation of the current study is that a single MHCII allele
was used in the experiments. Therefore, further experiments must
be conducted to confirm a common mechanism of DM-mediated
peptide exchange across various MHCII alleles. If DM acts to
promote peptide binding groove destabilization through disruption
of peptide/MHCII interactions near the P1 pocket, the effect of
MHCII P1 polymorphism may also provide additional insights
into the mechanism of DM-mediated exchange. Preliminary
experiments with other human MHCII alleles confirm the
presence of cooperativity in the absence of DM, supporting the
hypothesis that the total distributed binding energy available to the
peptide/MHCII complex contributes to complex formation,
whether from hydrogen bonds or hydrophobic ‘‘anchors’’.
Therefore we do not anticipate the need of an alternative
mechanism to explain the outcome of DM interaction with
different MHCII alleles.
How might the ‘‘compare-exchange’’ mechanism be applied to
our current understanding of epitope selection in vivo? Based on
our data, an attractive hypothesis would be that DM evolved to
accelerate the process of generating the highest stability peptide/
MHCII complexes within a given pool of available peptide
sequences within the MIIC. Currently, it is unclear how many
cycles of peptide exchange a peptide/MHCII complex undergoes
prior to egress from the MIIC. A specialized cellular substructure
has been identified in which such decisions may be made [38], but
on what basis is still unclear. One can envisage termination of the
exchange reaction based on generation of a true DM-mediated
‘‘compact’’ conformation. The answer may lie in elucidating the
molecular details of the resolution of the tetramolecular complex.
The ‘‘compare-exchange’’ mechanism proposed here for DM
mechanism might also be important for antigen processing via the
MHC class I pathway. MHC class I processing involves proteins
structurally related to MHCII, and both classes of MHC
molecules undergo peptide-dependent conformational change.
Furthermore, the majority of MHC class I alleles requires the
intervention of the tapasin-ERp57 heterodimer to optimize their
peptide cargo [40]. The ‘‘compare-exchange’’ mechanism may
provide additional insights into the biology of MHC antigen
processing, and may also be generally applicable to other
biological systems in which protein receptors must bind diverse
yet structurally related ligands.
Materials and Methods
Peptide Synthesis
Peptides derived from the sequence GPKYVKQNTLKLAT,
representing residues 306–318 of the hemagglutinin protein from
influenza A virus (H3 subtype), are described in table 1. The N-
terminal Gly facilitated labeling. Side chains in the HA peptide are
numbered relative to the P1 Tyr residue [41]. The sequence
PVSKMRMATPLLMQA represents residues 87–101 of the
CLIP peptide [42]. Peptides were synthesized by standard solid-
phase methods, purified by HPLC, and confirmed by mass
spectrometry. N-terminal labeling with FAM (Molecular Probes)
or LC-LC biotin (Pierce) was performed on the resin before
deprotection, and then peptides were cleaved and purified by
HPLC. For the spin labeling, the HA peptide sequence was
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chemistry and standard protocols, purified by HPLC and
confirmed by MALDI-TOF mass spec (Protein Nucleic Acid
Shared Facility- MCW). Subsequently, 10 mg of the sulfhydryl-
specific EPR probe MTSL ((1-oxyl-2,2,5,5-tetramethyl-3-pyrro-
line-3-methyl) methanethiosulfonate spin label; Toronto Research
Chemicals) previously dissolved in 200 ml of DMSO was added to
20 mg of purified peptide dissolved in 10 ml of 5% acetic acid.
After 5 h of incubation (dark, rocking, room temperature), the
coupling was monitored by RP-HPLC, the peptide re-purified by
RP-HPLC and verified by MALDI-TOF mass spec. N-terminal
labeling with QSY-7 (Molecular Probes) of wtHA was performed
according to the manufacture’s protocol after peptide purification.
Unbound probe was purified by HPLC.
Expression and Purification of Recombinant Soluble DR1
and DM Protein
Recombinant soluble empty (peptide free) DR1 was produced
and immunoaffinity purified from a stably transfected Drosophila S2
insect cell line essentially as described [43]. It is known that DR1
produced in S2 cells might have insect-derived peptide loosely
bound once purified. Nevertheless the increased peptide binding
capacity, increased binding rate and decreased pH dependence of
peptide binding as compared to mammalian-derived DR1 indicate
that, as isolated, the antigen binding site is largely empty (.85%)
[43]. Soluble FLAG epitope tagged DM was isolated from a stably
transfected Drosophila S2 cell line as described [9]. To avoid
contamination with FLAG peptide, DM elution from the resin was
performed with 0.1 M glycine HCl, pH 3.5. Both DR1 and DM
proteins were purified and buffer exchanged into PBS (7 mM Na
+/
K
+ phosphate, 135 mM NaCl, pH 7.4) using centrifugal ultra-
filtration (Amicon). Purity (.95%) was confirmed by SDS-PAGE
stained with GelCode Blue Stain Reagent (Pierce). DR1 and DM
proteins were quantified by measuring the UV absorbance @
280 nm using an E280 of 56340 M
21 cm
21 before use.
PAGE analysis of DM Mediated and Intrinsic Peptide
Dissociation
DR1/peptide complexes were formed by incubating 1 mM DR1
protein with a 10-fold molar excess of FITC-labeled peptide in
50 mM NaH2PO4 and 50 mM of sodium citrate (pH 5.3) and
protease inhibitors for 16 h @ 37uC. DR1/peptide complexes
were then purified from unbound peptide by buffer exchange into
PBS with a Centricon-30 spin filter that had been pre-incubated
with 25 mM MES (pH 6.5). Purified DR1/peptide complexes
were then quantified by reading the UV absorbance @ 280 nm,
factoring in an E280 of 1280 M
21 cm
21 for the Tyr residue and
10846 M
21 cm
21 for the fluorescein present in the bound
peptide. Purified DR1/peptide complexes (85 nM) were then
incubated with 10 mM unlabeled HA peptide @ 37uCi n5 0m M
NaH2PO4 and 50 mM of sodium citrate (pH 5.3).To prevent
nonspecific adherence of the protein, siliconized tubes were used.
At various time points, aliquots of the reaction were removed and
quenched with 0.5 M Tris-HCl (pH 8.0) in gel loading buffer and
immediately placed on ice. The aliquots were then loaded onto a
5/12% native PAGE gel and quickly separated by electrophoresis
at 150 V for 30 min. FITC-peptide/DR1 complexes were then
visualized using a FluorImager (Molecular Dynamics). Data was
normalized and expressed as the % of FITC-peptide/DR1
complex remaining relative to the complex at t=0, and fit to a
single or double exponential model. Each experiment was
performed in triplicate, and the reported dissociation rate reflects
the mean6SD of three independent experiments.
Fluorescence Polarization Dissociation and Association
Measurements
DR/peptide complexes were formed by incubating 1 mM DR1
with a 10-fold excess of FAM-labeled peptide as described above,
and purified from unbound peptide by buffer exchange into PBS
(pH 7.4) with a Centricon YM-30 spin filter (Amicon). 100 nM of
purified DR1/peptide complexes were incubated with 100-fold
excess of unlabeled HA 306-318 peptide in the presence of 3-fold
excess DM. In some experiments either the sequence or the
concentration of the exchange peptide was varied. Reactions were
performed @ 37uC in 50 mM sodium citrate/sodium phosphate
buffer at pH 5.0–5.3 and were covered with mineral oil to prevent
evaporation. For the association assay, equimolar DR1 and FAM-
labeled peptide were co-incubated with 3-fold excess of DM.
Fluorescence polarization was monitored after addition of the
peptide and DM until equilibrium was reached. To avoid non-
specific adherence of the protein, black polystyrene 96-well plates
were used (Corning). Measurements were performed using a
Wallac VICTOR counter (PerkinElmer Wallac) with the excita-
tion wavelength=485 nm and emission wavelength=535 nm.
Specific control groups included (a) protein only, (b) peptide only,
and (c) buffer only, and were used for background correction. FP
and anisotropy are mathematically related ways of expressing
parallel:perpendicular emission ratios and are easily interconvert-
ed. Although FP is approximately linear with respect to the ratio of
free:bound peptide, FP was converted to anisotropy (which is
exactly linear) by the following equation A=2*FP/(32FP) where
A is anisotropy and FP indicates fluorescence polarization in mP
units. Anisotropy values were fitted either according to a single- or
a bi- exponential decay model. Each experiment was performed in
triplicate, and the reported dissociation rate reflects the mean6SD
of three independent experiments.
Competitive Peptide Binding Assay
DR1(20 nm)wasincubated with20 nm biotinylated HA peptide
in PBS (0.1% BSA, 0.01% Tween 20, 0.1 mg/ml 4-(2-aminoethyl)-
benzene sulfonyl fluoride, 0.1 mM iodoacetamide, 5 mM EDTA,
0.02% NaN3, pH 7.2) in the presence of varying amounts of
inhibitor peptides for 3 days at 37uC. The incubation time ensures
the majority (.65%) of DR1 protein participates in the peptide
binding reaction to reach equilibrium. Bound biotinylated peptide
was detected using a solid-phase immunoassay and Eu
2+ labeled
streptavidin [44]. Plates were read using a Wallac VICTOR
counter (PerkinElmer Wallac). Data was fit to a logistic equation
y=a/[1+(x/x0)
b]. IC50 values were obtained from the curve fit of the
binding data and converted to KD values by using the equation
KD=(IC50)/(1+[bHA]/KD,bHA)) in which KD,bHA was set equal to
14 nM on the basis of the results of the direct binding of bio-HA
peptide to DR1. Each point represents the mean and SD of three
independent experiments performed in quadruplicate. Because
peptide/MHCII binding represents a multistep reaction, the IC50
for a competitive binding assay may not be directly proportional to
the KD. While this can be offset by long incubations relative to half
life, we study low affinity peptides where half-lives are impossible to
determine. Therefore, the values of affinity reported herein should
be considered as apparent KD values.
EPR Measurements
The spin labeled peptide was bound to DR1 for 3 days @ 37uC
in acid buffer (pH 5.0) and the unbound peptide removed by
twelve cycles of ultrafiltration through a Centricon YM-30 spin
filter (Amicon) previously incubated with 200 mlo f2 5mM MES.
25–30 mM of purified DR1/peptide complex were incubated for
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peptide or 3-fold molar excess of DM or in their absence as a
control. After 24 hr, 3-fold excess of DM or 100-fold excess of
unlabeled exchange was added to the first two reactions. X-band
EPR spectra of the three samples (,20 mL) contained in glass
capillaries were recorded on a Bruker ElexSys E500 fitted with a
super high Q cavity. Spectra were acquired at room temperature
over a 100 G range with an incident microwave power of 10 mW
at the following timepoints: 0, 24 24.5, 25.5, 26.5, 27.5, 28 hr.
After 47 hr DM and unlabeled HA were added to the control and
spectra of this sample were acquired as above. Each timepoint
typically represents the average of 9–25 scans collected over 6–
18 min, respectively, and is plotted according to the time at which
the first of the averaged scans was recorded. Spectral analysis to
obtain the percentage of free peptide for each timepoint was
carried out using spectral subtraction and double integration
methods with software kindly provided by Dr. Christian Altenbach
(University of California, Los Angeles).
Calculation of Cooperative Effects
We utilized a multiple substitution strategy previously used to
identify interacting partners during protein folding [23,26]. To
normalize the t1/2 values of a given peptide/MHCII complex, we
define the effect of each substitution as the ratio of the substituted
measurement over that of the DR1/wtHA value (Dt1/2). For
calculating cooperativity, the effect of multiple substitutions is
measured directly (observed value). The expected value for a
combination of substitutions is calculated as the product of the
individual substitutions [e.g. Dt1/2,exp x,y=(Dt1/2, x)6(Dt1/2, y)].
For peptides with three substitutions, the expected value would be
the product of all the different substitutions [e.g. Dt1/2,exp
x,y,z=(Dt1/2, x)6(Dt1/2, y)6(Dt1/2, z)]. The cooperativity is the
ratio of the expected to observed (C=exp/obs) values for Dt1/2.A
value of 1 for the ratio of expected/observed indicates no
cooperativity, for it would suggest independent energetic contri-
bution from each substitution. Cooperativity is evidenced when
the ratio of expected/observed is not equal to 1. Since each
measurement (both expected and observed) is affected by an error
and cooperativity is calculated as their ratio, its value is affected by
the propagation of the relative errors.
Thus, error on cooperativity is calculated through standard
error propagation: DC~C|
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
Dexp=exp ðÞ
2z Dobs=obs ðÞ
2
q
and,
in a ln plot, the error is calculated as: DCln=DC/C.
FRET
The extent of a possible bi-peptide colocalization was measured
fluorometrically using a 5-carboxyfluorescein (5-FAM)/QSY-7
fluorescence resonance energy transfer (FRET). QSY-7 is a non-
fluorescent diarylrhodamine derivative that has strong absorption
in the FAM emission spectrum without direct acceptor excitation.
QSY-7 extinction coefficients are typically in excess of
90,000 cm
21M
21and absorption spectra of the conjugates are
insensitive to pH between 4 and 10. Fluorescence quantum yields
are typically ,0.001 in aqueous solution. QSY-7 presents high
chemical stability of the conjugates and very good resistance to
photobleaching. In a standard FRET-based proximity study, the
residual fluorescence of 5-FAM is recovered and can be monitored
at excitation/emission wavelengths of 480610/520610 nm.
DR1/peptide complexes were formed by incubating 1 mM DR1
with a 10-fold excess of FAM-labeled peptide and purified as
described above. 100 nM of purified DR1/peptide complexes
were incubated with 100-fold excess of QSY-7 labeled HA 306-
318 peptide in the presence of a 3-fold molar excess of DM.
Specific control groups included (a) FAM-HA only, (b) FAM-HA
and QSY-7-HA, (c) FAM-HA, QSY-7-HA and DM, (d) buffer
only (e) protein only, with (d) and (e) used for background
correction. The change in fluorescence (expressed as relative
fluorescence units) was monitored at 5-min intervals for 1 h @
37uC using a Wallac VICTOR counter (PerkinElmer Wallac) with
an excitation wavelength=485 nm and an emission wave-
length=535 nm. Data were analyzed using an unpaired Student’s
t test (two groups). In all statistical tests, differences were
considered significant when p,0.05. Data are presented as
mean6S.E.M. Statistical analysis was performed using the
program SigmaPlot for Windows, version 9.0 (Systat Software,
Inc., San Jose, CA).
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